Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-01-30
1982-06-01
Torrence, Dolph H.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424251, 424273R, 424274, 544331, 544332, 548315, 548316, 564104, 548544, 548546, 548557, 548558, 548550, 548561, C07C12508, C07D20730, A61K 3140, A61K 31165
Patent
active
043328229
ABSTRACT:
Novel cyanoguanidine derivatives having the formula ##STR1## wherein Ar is a phenyl or pyrrol-1-yl group substituted by one or more substituents selected from halogen, trifluoromethyl, lower alkyl, lower alkoxy and nitro and R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are each independently hydrogen or lower alkyl or R.sub.1 and R.sub.2 taken together form dimethylene or trimethylene, lower blood pressure and, in some cases are also anti-ulcer agents.
REFERENCES:
patent: 3632645 (1972-01-01), Bream et al.
patent: 3634508 (1972-01-01), Bream et al.
patent: 3822262 (1974-07-01), Bream et al.
patent: 4140793 (1979-02-01), Ward
patent: 4265905 (1981-05-01), Shen et al.
Adams et al., J. Org. Chem. 17, pp. 1162-1171 (1952).
Scholtysik et al., Arzneim. Forsch. 25, pp. 1483-1491 (1975).
Jackson Richard K.
John Wyeth & Brother Limited
Torrence Dolph H.
LandOfFree
Guanidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849611